BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25060612)

  • 1. Governance in EU illicit drugs policy.
    Edwards C; Galla M
    Int J Drug Policy; 2014 Sep; 25(5):942-7. PubMed ID: 25060612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-level governance: The way forward for European illicit drug policy?
    Chatwin C
    Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why a governance perspective could contribute to improving drug policy and engaging the international development community: lessons from Colombia.
    Schultze-Kraft M
    Int J Drug Policy; 2014 Sep; 25(5):1038-9. PubMed ID: 24433814
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards good governance in drug policy: evidence, stakeholders and politics.
    MacGregor S; Singleton N; Trautmann F
    Int J Drug Policy; 2014 Sep; 25(5):931-4. PubMed ID: 25086908
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards revision of the UN drug control conventions: harnessing like-mindedness.
    Bewley-Taylor DR
    Int J Drug Policy; 2013 Jan; 24(1):60-8. PubMed ID: 23036654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking 'flexibilities' in the international drug control system-Potential, precedents and models for reforms.
    Collins J
    Int J Drug Policy; 2018 Oct; 60():107-114. PubMed ID: 28129946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction and the global drug control regime: contemporary problems and future prospects.
    Bewley-Taylor DR
    Drug Alcohol Rev; 2004 Dec; 23(4):483-9. PubMed ID: 15763753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transnational social movement theory and the waning war on drugs: Case studies from UNGASS 2016.
    Mostyn B; Gibbon H
    Int J Drug Policy; 2018 Jan; 51():148-155. PubMed ID: 29273560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Governing through problems: the formulation of policy on amphetamine-type stimulants (ATS) in Australia.
    Fraser S; Moore D
    Int J Drug Policy; 2011 Nov; 22(6):498-506. PubMed ID: 22054738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sector cooperation in health-enhancing physical activity policymaking: more potential than achievements?
    Hämäläinen RM; Aro AR; Lau CJ; Rus D; Cori L; Syed AM;
    Health Res Policy Syst; 2016 Apr; 14(1):33. PubMed ID: 27129850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is good governance in the context of drug policy?
    Singleton N; Rubin J
    Int J Drug Policy; 2014 Sep; 25(5):935-41. PubMed ID: 24768218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How well do international drug conventions protect public health?
    Room R; Reuter P
    Lancet; 2012 Jan; 379(9810):84-91. PubMed ID: 22225673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.
    Monaghan M
    Int J Drug Policy; 2014 Sep; 25(5):1025-30. PubMed ID: 24635973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit drugs policy through the lens of regulation.
    Ritter A
    Int J Drug Policy; 2010 Jul; 21(4):265-70. PubMed ID: 20005691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.